News About: Goverment
KFDA to elucidate possible link between sibutramine therapy and adverse events
The Korea Food and Drug Administration says it will reach a conclusion on safety of sibutramine by next month after full review of clinical data from the Sibutramine Cardiovascular Morbidity/Mortality Outcomes in Over...
Rules on drug sales should be eased, KDI says
Over the counter drugs, such as digestive pills that don't need a doctor's prescription, could be sold at supermarkets in the near future, and people without a pharmacist's license may also be allowed to run pharmacie...
KFDA recruits 77 staff
The Korea Food and Drug Administration said it has recruited a total of 77 staff to prepare for its transfer to Osong, North Chungbuk Province in November.
The new workforce with master's or Ph.D. degrees in pharm...
Government urged to finance drugmakers
Korea has unveiled an ambitious vision to develop 15 new drugs through the creation of a large-scale R&D fund and undertaking clinical studies on behalf of local firms.
The Ministry for Health, Welfare and Family A...
Health ministry supports anti-rebate plan
With the recent Korea Pharmaceutical Manufactures Association (KPMA)’s protest advertisements against the cash reward plan for doctors and pharmacists that would put mounting pressure to lower drug prices, the Health ...
Guideline for chemotherapy generics to be formulated
The Korea Food and Drug Administration is considering drafting a guideline for approval of oral chemotherapy generics, including Xeloda (Capecitabine), as part of effort to encourage local drug makers to market them w...
Clinics prescribe less antibiotics against acute upper respiratory tract infection
The antibiotics prescription rate of clinics for treatment of acute upper respiratory tract infection plunged to 51.1 percent in the latter half of last year, down 5.17 percent from the same period of 2008, the Health...
More fair, reliable criteria needed for cost-effectiveness of antihypertensive agents
The government will have to undertake controversial drug pricing and reimbursement policies despite opposition from pharmaceutical companies, according to the Korean Pharmacists for Democratic Society.
The civic gr...
53 Hepsera generics waiting for regulatory approval
A total of 53 domestic drug makers are waiting for the green light of the Korea Food and Drug Administration to launch their generics for GlaxoSmithKline’s Hepsera (adefovir dipivoxil) as the re-examination period of ...
Korea lags in research spending for development of anticancer drugs
Korea has lagged behind Japan and other developed nations in research and development (R&D) activities over the development of anticancer agents, undermining present and future growth potential, a local professor said...
